News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Raul Cordoba: Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma
Photo generated from www.thelancet.com
Jun 19, 2024, 06:53

Raul Cordoba: Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma

Raul Cordoba shared on X:

“HOT OFF THE PRESS!

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.”

Read further
Source: Raul Cordoba/X

Raúl Córdoba Mascuñano, MD, PhD is a specialist in hematology and hemotherapy. He is the Coordinator of the Lymphoma Unit at University Hospital Fundación Jiménez Díaz, Madrid, Spain. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.

cancer Cancer research EPCORE NHL-1 Epcoritamab Epcoritamab monotherapy follicular lymphoma lymphoma multicentre study OncoDaily Oncology Raul Cordoba
Special Coverage
Blog
Feb 11, 2025, 11:25
Rami Manochakian: Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists
Blog
Feb 11, 2025, 11:18
Ignacio Garrido-Laguna: 2 posterchilds clinical trials make difference in pancreatic cancer
Blog
Feb 11, 2025, 11:11
Silvia Brotea-Mosoiu is appointed Co-Chair of Education Working Group at ESO
Blog
Feb 11, 2025, 11:06
Let’s Inspire Action together, by joining the ICCD2025 - Childhood Cancer International
Blog
Feb 11, 2025, 11:01
ESO's Basics in Breast Cancer Surgery course
Blog
Feb 11, 2025, 10:56
Enrique Grande: Meta-analysis compares ablative therapies for localized renal cell carcinoma
Blog
Feb 11, 2025, 10:48
Toufic Kachaamy: Bridging the Gap Between Gastroenterology and Oncology
Blog
Feb 11, 2025, 10:45
Design to dissemination - Research bootcamp at ESTRO 2025
Blog
Feb 11, 2025, 10:42
Douglas Flora: How community oncology should be done
Blog
Feb 11, 2025, 10:32
Albert Bourla: A bold aspiration to deliver eight potential cancer breakthroughs by 2030
Blog
Feb 11, 2025, 10:28
Recognizing the power of women in oncology - City Cancer Challenge
Blog
Feb 11, 2025, 10:28
Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto